Cats Whiskers and Java Tea- diabetes treatment

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
139
Cats Whiskers and Java Tea- diabetes treatment

Nutritional analysis PROVES the effectiveness of herbal medicine in treating diabetes


http://www.alternativemedicine.news/2018-07-0...betes.html

It stands to reason that since a lot of drug treatments in Western medicine are rooted from plant-based sources, actual plants that are used as medicine should be considered in the same regard. Of course, that isn’t the case with most medicinal plants, as the same community that has approved its synthetic derivatives for use is the same one blocking herbal medicine from widespread use. Fortunately, there are times where science actually proves that traditional applications of medicinal plants can be verified after a thorough analysis.

Such is the case of cat’s whiskers (Orthosiphon stamineus), a herb used in traditional medicine to treat diabetes, as a study in BMC Complementary and Alternative Medicine has validated this claim using a novel tool to measure anti-diabetic activity. The plant is popular in Southeast Asia, where it’s used to treat a wide range of diseases such as diabetes, hypertension, and even rheumatism. In these areas, it’s consumed as part of a herbal infusion called Java tea, and it’s the second most popular alternative treatment for diabetes, following the bitter gourd.

For a plant that’s known as a potent treatment for diabetes, not a lot of studies have been done to verify this claim. At the time of the study, researchers claimed that their paper was the first of its kind to analyze the anti-diabetic property of cat’s whiskers using a metabolomic approach.

In the study, researchers used extracts derived from the leaves of cat’s whiskers, which were then dissolved in different solvents – namely, water (aqueous), ethanol, equal-part water and ethanol, and methanol. These were then administered to rats that were injected with streptozotocin to mimic the effects of diabetes. During the experiment, which ran for 14 days, rats were fed with their respective extracts. The researchers studied metabolic activity by testing the urine from the samples using the NRM metabolomics approach.

Researchers found that the aqueous extract of cat’s whiskers exhibited anti-diabetes action similar to glibenclamide, a drug which boosts insulin production to reduce glucose in the blood. The extract also contained multiple phytochemicals that have potent antioxidant activity, including rosmarinic acid, protocatechuic acid, caffeic acid, tetramethoxy chalcone derivatives, ferulic acid, syringic acid, kaempferol methyl ether, succinic acid, protocatechuic acid hexoside, and luteolin.

They also identified metabolic pathways that were targeted by the aqueous extract. Of these pathways, cat’s whiskers impacted the pathways that regulate ketone synthesis and degradation – which could be useful in diets such as the ketogenic diet.

“These pathways represent their potential as the targeted pathways of OSAE treatment in diabetic condition,” they added.

All in all, the team found that the herb cat’s whiskers could be a promising agent in diabetes treatment, given its ability to regulate glucose formation, lipid and amino acid build-up, and its effect on various metabolic pathways. “The results of this study validated the ethnopharmacological use of [cat’s whiskers] in diabetes and unveiled the biochemical and metabolic mechanisms involved,” the researchers concluded in their report.

Indeed, many types of medicinal plants are proven to be effective in treating various diseases. With studies like these, it’s not far off to think that more people will consider how potent these cures, despite the industry’s best efforts to put a lid on it. (Related: Turmeric and omega 3s can cure diabetes – but you’ll never hear that from your doctor.)

Buy at Amazon.
https://www.amazon.com/Orthosiphon-Perennial-...B00DPK04ZS
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 176

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 221

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 183

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 256

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 150

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 140

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 863

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 437

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 63

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 578

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Response to Aluminium Tariff Threats and Implications

Updated Category News Views 121

Market Insights on Aluminium Pricing and Tariffs The aluminium market has been under scrutiny as recent events unfold regarding potential tariffs on Canadian imports. Despite rising aluminium prices for U.S. consumers since the presidential election, the increase has remained relatively moderate. This suggests that industry players are not overly concerned about the...

Continue Reading
Understanding the Booming Healthcare Asset Management Market

Updated Category News Views 230

Healthcare Asset Management Market Overview The Healthcare Asset Management market has been experiencing remarkable growth, with projections estimating its value to exceed USD 166.82 billion. This rapid expansion is driven by an impressive compound annual growth rate (CAGR) of 23.1% from 2024 to 2032. This article delves into the reasons behind this growth and what the...

Continue Reading
T1 Energy Inc. Faces Shareholder Investigation: What You Need to Know

Updated Category News Views 454

Understanding the Investigation of T1 Energy Inc. T1 Energy Inc. (NYSE: TE) is currently the focus of an important investigation launched by Purcell & Lefkowitz LLP, aimed at safeguarding the rights of its shareholders. This inquiry is centered on whether the directors have acted in accordance with their fiduciary duties regarding significant recent corporate actions. Why...

Continue Reading
Kimberly-Clark's Strategic Move to Shape Health and Wellness Market

Updated Category News Views 183

Kimberly-Clark's Transformative Acquisition In a remarkable move to bolster its position in the personal care products sector, Kimberly-Clark Corporation is poised to acquire Kenvue. This acquisition will create a formidable entity within the health and wellness market, valued at an impressive $32 billion. Kimberly-Clark, recognized for its commitment to sustainability...

Continue Reading
ADC Therapeutics Welcomes New Talent with Employee Grants

Updated Category News Views 106

ADC Therapeutics Expands Team with New Inducement Grant ADC Therapeutics SA (NYSE: ADCT), a leader in the field of antibody drug conjugates (ADCs), recently made headlines by offering a grant of options to acquire 6,000 of the company's common shares to a newly hired employee. This strategic move highlights the company's commitment to attracting top talent essential for...

Continue Reading